The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Katra Phytochem (India) Pvt Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
BSE has received a disclosure under Regulation 29(2) of SEBI's Takeover Regulations from Katra Phytochem (India) Pvt Ltd, an entity associated with Kerala Ayurveda Ltd. This regulation mandates promoters or persons acting in concert to report any acquisition or disposal of shares that triggers disclosure thresholds (typically 2% or more of share capital, or a change beyond 2% from the last disclosure). The specific direction of the transaction—whether it is a purchase or sale by Katra Phytochem—and the exact number of shares involved are not available from the headline alone. Katra Phytochem appears to be a promoter/promoter-group entity of Kerala Ayurveda Ltd based on the context of SAST filing.
SAST disclosures by promoter-group entities are routine regulatory filings that can signal changes in promoter holding. Shareholders should look for the detailed disclosure to know if the promoter group has increased or reduced its stake, which may affect confidence in the stock depending on the direction of the transaction.